BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32579884)

  • 21. Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer.
    Huh CW; Jung DH; Kim JH; Lee YC; Kim H; Kim H; Yoon SO; Youn YH; Park H; Lee SI; Choi SH; Cheong JH; Noh SH
    J Surg Oncol; 2013 Feb; 107(2):124-9. PubMed ID: 22991272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does early signet ring cell gastric carcinoma carry a worse prognosis?].
    Triboulet JP; Gronnier C; Messager M; Piessen G; Mariette C;
    Bull Acad Natl Med; 2013 Feb; 197(2):443-55; discussion 455-6. PubMed ID: 24919373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.
    Charalampakis N; Nogueras González GM; Elimova E; Wadhwa R; Shiozaki H; Shimodaira Y; Blum MA; Rogers JE; Harada K; Matamoros A; Sagebiel T; Das P; Minsky BD; Lee JH; Weston B; Bhutani MS; Estrella JS; Badgwell BD; Ajani JA
    Oncology; 2016; 90(5):239-47. PubMed ID: 27046280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.
    Pokala SK; Zhang C; Chen Z; Gamboa AM; Cristofaro SL; Keilin SA; Cai Q; Willingham FF
    J Gastrointest Surg; 2018 Apr; 22(4):569-577. PubMed ID: 29313289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signet ring gastric and esophageal adenocarcinomas: characteristics and prognostic implications.
    Khan N; Donohoe CL; Phillips AW; Griffin SM; Reynolds JV
    Dis Esophagus; 2020 Nov; 33(11):. PubMed ID: 32378712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma.
    Wang JB; Lin MQ; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Huang CM
    Asian J Surg; 2021 Jan; 44(1):116-122. PubMed ID: 32467008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation.
    Patel VR; Hofstetter WL; Correa AM; Agarwal A; Rashid A; Bhutani MS; Lin SH; Ajani JA; Swisher SG; Maru DM
    Ann Thorac Surg; 2014 Sep; 98(3):1064-71. PubMed ID: 25038008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
    Turgeon MK; Gamboa AC; Rupji M; Lee RM; Switchenko JM; El-Rayes BF; Russell MC; Cardona K; Kooby DA; Staley CA; Maithel SK; Shah MM
    Ann Surg Oncol; 2021 Jan; 28(1):97-105. PubMed ID: 32524459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
    Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
    ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Poultsides GA; Pawlik TM; Weber SM; Schmidt CR; Votanopoulos KI; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Levine EA; Jin LX; Cho CS; Bloomston M; Winslow ER; Russell MC; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2015 Apr; 22(4):1243-51. PubMed ID: 25316491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry.
    Schlesinger-Raab A; Mihaljevic AL; Egert S; Emeny R; Jauch KW; Kleeff J; Novotny A; Nüssler NC; Rottmann M; Schepp W; Schmitt W; Schubert-Fritschle G; Weber B; Schuhmacher C; Engel J
    Gastric Cancer; 2016 Jul; 19(3):713-22. PubMed ID: 26260874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
    Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior.
    Nafteux PR; Lerut TE; Villeneuve PJ; Dhaenens JM; De Hertogh G; Moons J; Coosemans WJ; Van Veer HG; De Leyn PR
    Ann Surg; 2014 Dec; 260(6):1023-9. PubMed ID: 24836142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma?
    Gronnier C; Messager M; Robb WB; Thiebot T; Louis D; Luc G; Piessen G; Mariette C;
    Surgery; 2013 Nov; 154(5):1093-9. PubMed ID: 24075273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States.
    Lin CL; Zhu GW; Huang YJ; Zheng W; Yang SG; Ye JX
    Saudi J Gastroenterol; 2020; 26(1):46-52. PubMed ID: 32031158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer.
    de Aguiar VG; Segatelli V; Macedo ALV; Goldenberg A; Gansl RC; Maluf FC; Usón Junior PLS
    Future Oncol; 2019 Feb; 15(4):401-408. PubMed ID: 30620220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.
    Gill S; Shah A; Le N; Cook EF; Yoshida EM
    J Clin Oncol; 2003 Jun; 21(11):2070-6. PubMed ID: 12775731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.